|
|
 | | | |
- close
- close
- close
- close
Achillion Pharmaceuticals (ACHN) |
Benzinga
May 15
Comment
Achillion Pharmaceuticals, Inc. (NASDAQ: ACHN) today announced the appointment of David Apelian, M.D., Ph.D., MBA, to the position of Executive Vice President and Chief Medical Officer, effective May 28, 2013. Dr. Apelian wll assume responsibility...
StreetInsider.com
May 7
Comment
Visit StreetInsider.com at http://www.streetinsider.com/Earnings/Achillion+Pharmaceuticals%2C+Inc.+%28ACHN%29+Posts+Q1+Loss+of+14cShare/8310329.html for the full story.
Benzinga
Apr 23
Comment
Achillion Pharmaceuticals (NASDAQ: ACHN) today announced updated interim safety and efficacy results, including early sustained virologic response (SVR4) data, from the pilot Phase 2 trial evaluating once-daily ACH-3102 plus ribavirin (RBV) in...
Stock Blog Hub
Apr 21
Comment
Achillion Pharmaceuticals, Inc. (ACHN) recently commenced international phase II studies on sovaprevir and ACH-3102 for the treatment of genotype 1 chronic hepatitis C (HCV). The trial will assess an all-oral 12-week interferon-free regimen...
StreetInsider.com
Apr 16
Comment
Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/Achillion+%28ACHN%29+Commences+ACH-3102+Phase+2/8254639.html for the full story.
Market Intelligence Center
Mar 28
Comment
Achillion Pharmac (NASDAQ: ACHN) closed Wednesday's trading session at $8.82. In the past year, the stock has hit a 52-week low of $5.42 and 52-week high of $11.36. Achillion Pharmac (ACHN) stock has been showing support around $8.39 and...
Benzinga
Mar 4
Comment
Piper Jaffray maintained Achillion Pharmaceuticals (NASDAQ: ACHN) with an Overweight rating and lowered the price target from $16.00 to $15.00.
Piper Jaffray said, "Achillion now holds proforma cash of $211 million following a recent 16.9...
Benzinga
Feb 22
Comment
Achillion Pharmaceuticals (NASDAQ: ACHN) announced today the pricing of an underwritten public offering of 15,000,000 shares of its common stock at a price to the public of $8.40 per share. The net proceeds to Achillion from the sale of the...
StreetInsider.com
Feb 20
Comment
Visit StreetInsider.com at http://www.streetinsider.com/Equity+Offerings/Achillion+Pharma+%28ACHN%29+Announces+%24125M+Common+Offering/8116844.html for the full story.
Suggest other news sources for this topic
more ▼WIKI ANALYSIS
WIKI ANALYSIS|
Error creating thumbnail: convert: unable to open image `/home/wikinvest/src_live_2/mediawiki/images/9/98/New_stock.png': No such file or directory @ blob.c/OpenBlob/2480. convert: unable to open file `/home/wikinvest/src_live_2/mediawiki/images/9/98/New_stock.png' @ png.c/ReadPNGImage/2889. convert: missing an image filename `/home/wikinvest/src_live_2/mediawiki/images/thumb/9/98/New_stock.png/35px-New_stock.png' @ convert.c/ConvertImageCommand/2800. |
The article on this company has not been written yet. If you're the first person to write this article, it's a sure thing that you'll be credited as a Top Contributor. For tips on getting started, check out the sample article. |
References
| |||||||
